ASCO 2020: BCMA CAR-T Race Heats Up Between Bristol And Janssen

 
• By Mandy Jackson
  
T cell lymphocyte with receptors to kill cancer cell in cancer immunotherapy 3D render
CAR-T cells targeting BCMA induce high responses in heavily pre-treated myeloma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences